Characteristics | All | EGFR-Mutated | ALK-Rearranged | |||
---|---|---|---|---|---|---|
N = 46 | % | N = 37 | % | N = 9 | % | |
Age | ||||||
Median (range), years | 62 (35–80) | 64 (50–80) | 51 (35–74) | |||
Sex | ||||||
Male | 19 | 41.3 | 14 | 37.8 | 5 | 55.5 |
Female | 27 | 58.7 | 23 | 62.1 | 4 | 44.4 |
Smoking status | ||||||
Never-smoker | 20 | 43.5 | 16 | 43.2 | 4 | 44.4 |
Current or former smoker | 23 | 50 | 18 | 48.6 | 5 | 55.5 |
Unknown | 3 | 6.5 | 3 | 8.1 | 0 | 0 |
Pack-years, median(range) | 32(2–114) | 32(2–114) | 29.5(13–48) | |||
ECOG performance status | ||||||
0 | 33 | 71.7 | 27 | 72.9 | 6 | 66.6 |
1 | 10 | 21.7 | 8 | 21.6 | 2 | 22.2 |
2 | 0 | 0 | 0 | 0 | 0 | 0 |
> 2 | 2 | 4.3 | 1 | 2.7 | 1 | 11.1 |
Unknown | 1 | 2.1 | 1 | 2.7 | 0 | 0 |
Tumor histology | ||||||
Adenocarcinoma | 42 | 91.3 | 34 | 91.8 | 8 | 88.8 |
NSCLC, NOS | 1 | 2.1 | 0 | 0 | 1 | 11.1 |
Unknown | 3 | 6.5 | 3 | 8.1 | 0 | 0 |
Stage | ||||||
Relapse | 25 | 54.3 | 22 | 59.4 | 3 | 33.3 |
III | 3 | 6.5 | 2 | 5.4 | 1 | 11.1 |
IV | 18 | 39.1 | 13 | 35.1 | 5 | 55.5 |
Presence of extrathoracic metastases | ||||||
Yes | 13 | 28.2 | 9 | 24.3 | 4 | 44.4 |
No | 33 | 71.1 | 28 | 75.6 | 5 | 55.5 |
Presence of brain metastases | ||||||
Yes | 5 | 10.8 | 2 | 5.4 | 3 | 33.3 |
No | 41 | 89.1 | 35 | 94.5 | 6 | 66.6 |